[Magnetic resonance imaging of brain tumors].
Investigating intracranial tumors, different MR-related methods permit not only morphological visualization of lesions but also give insights into their metabolism, resulting in information about the biological qualities of the respective tumor. Magnetic resonance protocols are selected based on the type and timing of onset of clinical signs. Combined information from imaging studies and spectroscopy facilitates the differential diagnosis between blastomatous and non-blastomatous lesions before and after therapy.
Prayer
Daniela
D
Klinische Abteilung für Neuroradiologie, Universitätsklinik für Radiodiagnostik, Währinger Gürtel 18-20, A-1090 Wien. daniela.prayer@univie.ac.at
Brugger
P C
PC
D001921:Brain / Q000473:pathology / Q000503:physiopathology; D001932:Brain Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000503:physiopathology / Q000556:secondary; D003937:Diagnosis, Differential; D017352:Echo-Planar Imaging; D004734:Energy Metabolism / Q000502:physiology*; D005500:Follow-Up Studies; D006801:Humans; D007089:Image Enhancement; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D009364:Neoplasm Recurrence, Local / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology; D011379:Prognosis; D012680:Sensitivity and Specificity